|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Chinese Stroke Center Alliance:a national effort to improve healthcare quality for acute stroke and transient ischaemic attack:rationale,design and preliminary findings显示文摘Background In June 2015,the Chinese Stroke Association(CSA)initiated the Chinese Stroke Center Alliance(CSCA)to establish the national hospital-based stroke care quality assessment and improvement platform.This article outlines its objectives,operational structure,patient population,quality improvement(QI)intervention tools,data elements,data collection methodology and current patient and hospital data.Methods The CSCA is a national,hospital-based,multicentre,voluntary,multifaceted intervention and continuous QI initiative.This multifaceted intervention includes stroke centre development,written care protocols,workshops and a monitoring/feedback system of evidencebased performance measures.The data coordinating centre of the CSCA resides at the China National Clinical Research Center for Neurological Diseases,Beijing Tiantan Hospital.results As of July 2017,1576 hospitals in China have contributed detailed clinical information to serve as a benchmark for the stroke care quality of 433264 patients with acute stroke/transient ischaemic attacks(TIA),including 352572(81.38%)acute ischaemic stroke,30362(7.01%)TIA,42080(9.71%)spontaneous intracranial haemorrhage,5505(1.27%)subarachnoid haemorrhage and 2745(0.63%)not specified stroke.Conclusion The CSCA programme is designed to establish a continuous national stroke registry and help healthcare providers develop stroke centres and treat patients in a consistent manner in accordance with accepted national guidelines and,ultimately,improve patient outcomes.It supports the CSA mission to reduce stroke burden in China. | Yongjun Wang Zixiao Li Yilong Wang Xingquan Zhao Liping Liu Xin Yang Caiyun Wang Hongqiu Gu Fuying Zhang Chunjuan Wang Ying Xian David Z Wang Qiang Dong Anding Xu Jizong Zhao Chinese Stroke Center Alliance investigators | 2018 | Stroke & Vascular Neurology2018，3，4： | 38 |
| 2 | Association of elevated hs-CRP and multiple infarctions with outcomes of minor stroke or TIA: subgroup analysis of CHANCE randomised clinical trial显示文摘Background and purpose The relationship of high-sensitive C-reactive protein(hs-CRP)levels and infarction numbers with the prognosis of stroke is uncertain.This study evaluated the association of different hs-CRP levels and infarction numbers with the prognosis of acute minor ischaemic stroke or transient ischaemic attack(TIA).Methods A subset of 807 patients with both hs-CRP measurement and baseline MRI was included from the Clopidogrel in High-risk Patients with Acute Non-disabling Cerebrovascular Events trial.The primary efficacy outcome was the occurrence of an ischaemic stroke at the 1-year follow-up.Infarction numbers were classified as multiple acute infarctions(MAIs),single acute infarction and no acute infarction(NAI).The association between different hs-CRP levels with different infarction numbers and the risk of any outcome was analysed using multivariable Cox regression models.Results Among the 807 patients,84(10.4%)patients had a recurrent ischaemic stroke within 1 year.After adjustment for conventional confounding factors,patients with both elevated hs-CRP levels and MAIs were associated with approximately 4.7-fold of risk of ischaemic stroke within 1 year(16.7% vs 3.5%,HR 4.68,95% CI 1.54 to 14.23,p=0.007),compared with those with non-elevated hs-CRP levels and NAI.Similar results were observed for the composite events.Conclusions Combined elevated hs-CRP levels and MAIs may increase 1-year stroke risk stratification efficiency in patients with minor ischaemic stroke or TIA compared with using those markers alone,which indicated that the combination of inflammatory and imaging markers might improve the effectiveness of risk stratification concerning minor ischaemic stroke or TIA. | Guangyao Wang Jing Jing Jiejie Li Yuesong Pan Hongyi Yan Xia Meng Xingquan Zhao Liping Liu Hao Li David Z Wang Yongjun Wang Yilong Wang | 2021 | Stroke & Vascular Neurology2021，6，1： | 11 |
| 3 | Low hematocrit worsens cerebral injury after prolonged hypothermic circulatory arrest inrats显示文摘 | Dian-San S Xiang-Rui W Yongjun Z | 2006 | Can JAnaeth2006，53，12： | 1 |
| 4 | A Critical Role of the PINCH-Integrin-linked Kinase Interaction in the Regulation of Cell Shape Change and migration显示文摘 | Yongjun Z Lida G Ka C | 2002 | J Biol Chem2002，277，： | 1 |
| 5 | Chinese guidelines for the see- ondary prevention of ischemic stroke and transient ischemic attack 2010显示文摘 | Yongjun W Suming Z Liqun Z | 2012 | CNS Neurosc Therapeut2012，18，2： | 1 |
| 6 | The Analysis of Industrial Xanthoceras sorbifolia Forest-Oil Integration'sProspects显示文摘 | Yongjun D Qiuliang Z Huijun A | 2012 | Procedia Environmental Sciences2012，，12： | 1 |
| 7 | A critical role of the PINCH integrin linked kinase interaction in the regulation of cell shape change and migration显示文摘 | Yongjun Z Lida G Ka C | 2002 | J Biol Chem2002，277，7： | 1 |
| 8 | Nanoparticle as a new gene transferring vector in specific expression gene 显示文摘 | Heng G Yongjun L Yuehong Z | 2004 | Chin Med Sci J2004，17，4： | 1 |
| 9 | Prevalence of dyslipideamia in patients treated with lipe-lowering agents in China: results of the dyslipidemia international study(DYSIS) 显示文摘 | Shuiping Z Yongjun Wj Yiming Mj | 2014 | Atherosclerosis2014，235，： | 1 |
| 10 | Development of anodic film on Mg Alloy AZ91D 显示文摘 | Yongjun Z Chuanwei Y | 2006 | Surface and Coatings Technology2006，201，： | 1 |
| 11 | Electrochemical behaviors of anodized magnesium ahoy AZ91D in chloride containing aqueous solution 显示文摘 | Yongjun Z Chuanwei Y Fuhui W | 2005 | Corrosion Science2005，11，： | 1 |
| 12 | Nanoparticle as a new gene transferring vector in specific expression gene显示文摘 | Yongjun L Yuehong Z | 2002 | Chin Med Sci J2002，17，4： | 1 |
| 13 | From changes in local RAAS to structural remodeling of the left atrium:A beautiful cycle in atrial fibrillation显示文摘 | Yongjun Q Huanzhang S Wenxia Z | 2015 | Herz2015，40，3： | 1 |
| 14 | Study on the environmentally anodizing of AZglD magnesium alloy显示文摘 | Yongjun Z Chuanwei Y | 2002 | Surface and Coating Technology2002，161，： | 1 |
| 15 | Reliability and validity of a Chinese version of the Quality of Life in Epilepsy Inventory (QOLIE-89) 显示文摘 | YONGQING Z H CHENGYUN D YONGJUN W | 2007 | Epilepsy & Behavior2007，11，： | 1 |
| 16 | Study on the environmentally ano- dizing of AZ91D magnesium alloy显示文摘 | YONGJUN Z CHUANWEI Y | 2002 | Surface and Coating Tech- nology2002，161，： | 1 |
| 17 | Treating supratentorial intracerebral haemorrhage: hopeless? Or rethink our strategy显示文摘Intracerebral haemorrhage(ICH)is the deadliest(40%)among all strokes.1 There are about 2 million ICHs annually worldwide,but effective treatment is still lacking.An ICH volume of<30 cm3 may have a 30-day mortality of 19%.2 Clinical research on treating ICH has been focusing on blood pressure control,haemostatic therapy,surgical evacuation of the clot and effective drainage of intraven-tricular blood. | David Z Wang Liping Liu Guohua Xi Yongjun Wang | 2021 | Stroke & Vascular Neurology2021，6，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员